Sagan Paul

Sagan Paul is listed in filings as Director at OKTA Inc. This profile follows SEC Form 4 activity through Dec 22, 2025, including purchase activity. Recent filings connect the profile to OKTA Inc (OKTA) and Moderna Inc (MRNA). The current snapshot covers public activity from Mar 4, 2025 to Dec 22, 2025. Reported amounts are shown as $728.1K to $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.